We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.36B
AUM Growth
+$353M
Cap. Flow
+$69.5M
Cap. Flow %
1.09%
Top 10 Hldgs %
13.3%
Holding
1,175
New
186
Increased
412
Reduced
363
Closed
161

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$25.8M
2
AMZN icon
Amazon
AMZN
+$22.7M
3
XLNX
Xilinx Inc
XLNX
+$20.3M
4
EG icon
Everest Group
EG
+$18.9M
5
LKQ icon
LKQ Corp
LKQ
+$16.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$36M
2
UNH icon
UnitedHealth
UNH
+$29.5M
3
MRK icon
Merck
MRK
+$17.8M
4
BAX icon
Baxter International
BAX
+$17.5M
5
AAPL icon
Apple
AAPL
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Financials 17.64%
3 Consumer Discretionary 12.58%
4 Industrials 12.01%
5 Healthcare 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
976
DELISTED
Catalyst Pharmaceutical
CPRX
$148K ﹤0.01%
+47,400
New +$144K
IDT icon
977
IDT Corp
IDT
$1.6B
$147K ﹤0.01%
+26,100
New +$149K
BAS
978
DELISTED
Basis Energy Services, Inc.
BAS
$143K ﹤0.01%
12,900
-10,100
-44% -$142K
DHX icon
979
DHI Group
DHX
$166M
$142K ﹤0.01%
60,344
-7,584
-11% -$15.3K
SYRE icon
980
Spyre Therapeutics
SYRE
$8.87B
$142K ﹤0.01%
+535
New +$132K
EGIO
981
DELISTED
Edgio, Inc. Common Stock
EGIO
$139K ﹤0.01%
776
-804
-51% -$156K
DGICA icon
982
Donegal Group Class A
DGICA
$695M
$137K ﹤0.01%
+10,100
New +$144K
CDMO
983
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$135K ﹤0.01%
34,493
-52,925
-61% -$184K
GNMX
984
DELISTED
Aevi Genomic Medicine Inc
GNMX
$134K ﹤0.01%
120,619
+33,237
+38% +$50.5K
PFSW
985
DELISTED
PFSweb, Inc.
PFSW
$134K ﹤0.01%
+13,800
New +$136K
NOVN
986
DELISTED
Novan, Inc. Common Stock
NOVN
$130K ﹤0.01%
+4,413
New +$134K
RNWK
987
DELISTED
RealNetworks Inc
RNWK
$127K ﹤0.01%
34,254
PMBC
988
DELISTED
Pacific Mercantile Bancorp
PMBC
$125K ﹤0.01%
+12,799
New +$125K
ELVT
989
DELISTED
Elevate Credit, Inc.
ELVT
$118K ﹤0.01%
+14,000
New +$111K
VCYT icon
990
Veracyte
VCYT
$4.52B
$116K ﹤0.01%
+12,463
New +$87.6K
ASPN icon
991
Aspen Aerogels
ASPN
$387M
$108K ﹤0.01%
22,100
SIOX
992
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$105K ﹤0.01%
+5,813
New +$85.7K
EMKR
993
DELISTED
Emcore Corp
EMKR
$101K ﹤0.01%
2,003
-40
-2% -$2.02K
ATXS
994
DELISTED
Astria Therapeutics
ATXS
$95K ﹤0.01%
1,655
-694
-30% -$64K
ENT
995
DELISTED
Global Eagle Entertainment Inc.
ENT
$93K ﹤0.01%
1,479
-660
-31% -$28.8K
TLRA
996
DELISTED
Telaria, Inc.
TLRA
$93K ﹤0.01%
22,988
-53,017
-70% -$218K
VVUS
997
DELISTED
Vivus Inc
VVUS
$90K ﹤0.01%
12,725
-75,218
-86% -$453K
LPCN icon
998
Lipocine
LPCN
$17.1M
$84K ﹤0.01%
+3,818
New +$91K
ACTG icon
999
Acacia Research
ACTG
$450M
$82K ﹤0.01%
+19,654
New +$75.5K
RIGL icon
1000
Rigel Pharmaceuticals
RIGL
$680M
$81K ﹤0.01%
+2,850
New +$101K

Similar funds

Jacobs Levy Equity Management's Q2 2018 Portfolio in Review

As of Q2 2018, Jacobs Levy Equity Management held 1,175 positions worth $6.36B, up 5.9% from $6.01B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management's Q2 2018 filing shows 186 new, 412 increased, 363 reduced and 161 closed positions. Its largest new stake was LKQ Corp: 486,474 shares worth $15.5M. The largest sale was PepsiCo, an estimated $36M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2018 buy was LKQ Corp: 486,474 shares worth $15.5M.
  • Jacobs Levy Equity Management added most to ConocoPhillips in Q2 2018, an estimated $25.8M increase.
  • Jacobs Levy Equity Management's biggest Q2 2018 reduction was PepsiCo, cutting an estimated $36M.
  • Jacobs Levy Equity Management fully exited General Dynamics in Q2 2018, selling an estimated $11M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.36B portfolio in Q2 2018.
  • Jacobs Levy Equity Management opened 186 new positions and closed 161 in Q2 2018.
  • Jacobs Levy Equity Management's portfolio value rose 5.9% quarter-over-quarter to $6.36B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.